Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $671.43 | 3 | 55.7% |
| Food and Beverage | $534.36 | 36 | 44.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $750.83 | 7 | $0 (2017) |
| GlaxoSmithKline, LLC. | $402.09 | 30 | $0 (2023) |
| ABIOMED | $52.87 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $52.87 | 2 | ABIOMED ($52.87) |
| 2023 | $76.15 | 4 | GlaxoSmithKline, LLC. ($76.15) |
| 2022 | $141.53 | 11 | GlaxoSmithKline, LLC. ($141.53) |
| 2021 | $146.03 | 13 | GlaxoSmithKline, LLC. ($146.03) |
| 2020 | $38.38 | 2 | GlaxoSmithKline, LLC. ($38.38) |
| 2017 | $750.83 | 7 | Allergan Inc. ($750.83) |
All Payment Transactions
39 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/23/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $35.07 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/23/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $17.80 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/30/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: IMMUNOLOGY | ||||||
| 03/15/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: IMMUNOLOGY | ||||||
| 02/21/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: IMMUNOLOGY | ||||||
| 01/24/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: IMMUNOLOGY | ||||||
| 06/16/2022 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: IMMUNOLOGY | ||||||
| 06/16/2022 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $4.08 | General |
| Category: IMMUNOLOGY | ||||||
| 05/19/2022 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: IMMUNOLOGY | ||||||
| 05/17/2022 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $7.75 | General |
| Category: IMMUNOLOGY | ||||||
| 04/07/2022 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: IMMUNOLOGY | ||||||
| 03/03/2022 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: IMMUNOLOGY | ||||||
| 03/03/2022 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $0.14 | General |
| Category: IMMUNOLOGY | ||||||
| 02/10/2022 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: IMMUNOLOGY | ||||||
| 02/10/2022 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $0.42 | General |
| Category: IMMUNOLOGY | ||||||
| 01/06/2022 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: IMMUNOLOGY | ||||||
| 01/06/2022 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $0.60 | General |
| Category: IMMUNOLOGY | ||||||
| 12/01/2021 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2021 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: IMMUNOLOGY | ||||||
| 10/05/2021 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: IMMUNOLOGY | ||||||
| 10/05/2021 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $0.67 | General |
| Category: IMMUNOLOGY | ||||||
| 09/07/2021 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: IMMUNOLOGY | ||||||
| 09/01/2021 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $0.54 | General |
| Category: IMMUNOLOGY | ||||||
| 08/02/2021 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: IMMUNOLOGY | ||||||
| 08/02/2021 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $3.00 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 140 | 140 | $28,914 | $7,876 |
| 2022 | 5 | 109 | 122 | $21,955 | $6,006 |
| 2021 | 5 | 116 | 117 | $24,744 | $6,994 |
| 2020 | 7 | 373 | 376 | $67,076 | $13,388 |
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 78 | 78 | $22,074 | $5,996 | 27.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 24 | $5,448 | $1,337 | 24.5% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 12 | 12 | $1,236 | $486.60 | 39.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 26 | 26 | $156.00 | $57.20 | 36.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 56 | 56 | $15,846 | $3,987 | 25.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 18 | 18 | $4,087 | $1,166 | 28.5% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 11 | 11 | $1,133 | $448.55 | 39.6% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 11 | 23 | $805.00 | $373.70 | 46.4% |
| 81003 | Automated urinalysis test | Office | 2022 | 13 | 14 | $84.00 | $31.22 | 37.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 52 | 52 | $14,642 | $4,070 | 27.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 24 | 25 | $5,660 | $1,753 | 31.0% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 14 | 14 | $2,570 | $759.20 | 29.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 11 | 11 | $1,782 | $376.89 | 21.1% |
| 81003 | Automated urinalysis test | Office | 2021 | 15 | 15 | $90.00 | $33.75 | 37.5% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 106 | 106 | $28,726 | $5,596 | 19.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 134 | 135 | $25,380 | $5,010 | 19.7% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 42 | 43 | $6,966 | $1,413 | 20.3% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 26 | 26 | $4,966 | $1,053 | 21.2% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 18 | 19 | $665.00 | $180.20 | 27.1% |
| 81003 | Automated urinalysis test | Office | 2020 | 34 | 34 | $204.00 | $75.90 | 37.2% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2020 | 13 | 13 | $169.00 | $60.65 | 35.9% |
About Dr. Christopher Lee, M.D
Dr. Christopher Lee, M.D is a Anesthesiology healthcare provider based in Largo, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/10/2011. The National Provider Identifier (NPI) number assigned to this provider is 1780988469.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Lee, M.D has received a total of $1,206 in payments from pharmaceutical and medical device companies, with $52.87 received in 2024. These payments were reported across 39 transactions from 3 companies. The most common payment nature is "Travel and Lodging" ($671.43).
As a Medicare-enrolled provider, Lee has provided services to 738 Medicare beneficiaries, totaling 755 services with total Medicare billing of $34,264. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Practice Information
- Specialty Anesthesiology
- Other Specialties Internal Medicine, Occupational Medicine
- Location Largo, FL
- Active Since 01/10/2011
- Last Updated 10/10/2022
- Taxonomy Code 207L00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1780988469
Products in Payments
- BENLYSTA (Biological) $402.09
- Impella (Device) $52.87
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anesthesiology Doctors in Largo
Darren Wrede, Do, DO
Anesthesiology — Payments: $155,491
Tiffany Russ, Do, DO
Anesthesiology — Payments: $12,331
Dr. Jennifer Bunch, M.d, M.D
Anesthesiology — Payments: $8,972
Jonathan Dunn, Do, DO
Anesthesiology — Payments: $1,875
Dr. Lucas Nourse, D.o, D.O
Anesthesiology — Payments: $1,618
Dr. Brian Ida, D.o, D.O
Anesthesiology — Payments: $1,514